Based on this YouTube video's total view count of 422K views and industry-standard rates, the estimated total earning is $296 - $844 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Mass loss of trust with 422,169 views, 11,866 likes, and 7,334 comments. Experience the impact of this video content that has captured audience attention.

Is there a crisis of trust? https://ourworldindata.org/coronavirus John's free textbooks Download my two comprehensive but free educational text books or make a donation to the campbellteaching project using this link: http://159.69.48.3Russia https://www.youtube.com/watch?v=ijgNJpUes4Y https://www.dailymail.co.uk/news/article-10084049/Video-showing-Putin-coughing-meeting-emerges-forced-deny-having-Covid-19.html Infections, + 29,409 Deaths, + 973 = 217,000 Delta variant Vaccine hesitancy First dose, 33% Rolled out before trials Problem is not that bad Government had won the war on covid-19 Mr. Putin pulls out of G20 meeting due to 'diary clash' Two doses of Sputnik V ITU, 8,000 patients Patients becoming critical in 3 to 4 days Vaccination passports cost 70 euros Widespread public misconceptions Hygiene rules hardly followed Limited restrictions Limited mask wearing Official information not believed Indian summer just now Moscow may well cope New infectious disease hospital Regions, hospitals already full Molnupiravir, Merck, awaiting EMU US government at $700 (£515) per course Analysts at Harvard School of Public Health and King's College Hospital in London have found it costs just $17.74 (£13) to produce. Despite this, Merck and Ridgeback could earn $7 billion in profits by the end of the year. https://news.sky.com/story/covid-news-uk-latest-live-experts-discover-why-people-get-covid-toes-as-wales-introduces-vaccine-passports-12425651 https://www.fiercepharma.com/pharma/merck-molnupiravir-blockbuster-covid-19-pandemic-endemic-oral-antivirals-market That’s about $700 per course. Merck said it expects to make 10 million courses of the drug by the end of 2021, meaning $7 billion in revenue BBC Media Action £1,569,000 in 2019 - 2020 https://www.bbc.co.uk/mediaaction/about/funding https://www.bbc.co.uk/mediaaction/about/annual-reports https://www.bbc.co.uk/mediaaction/where-we-work We support the independent media essential to democracy and development. We inform, connect and inspire change in our audiences, providing trusted information, stories and ideas that generate discussion and bridge divides. helping to save lives and improve health, protect livelihoods, challenge inequality and build more peaceful and democratic societies. Coronavirus: lessons learned to date https://committees.parliament.uk/publications/7496/documents/78687/default/ in 2020 the UK did significantly worse in terms of covid deaths than many countries—especially compared to those in East Asia The UK’s pandemic planning was too narrowly and inflexibly based on a flu model which failed to learn the lessons from SARS, MERS and Ebola. In the first three months the strategy reflected official scientific advice to the Government which was accepted and implemented. When the Government moved from the ‘contain’ stage to the ‘delay’ stage, that approach involved trying to manage the spread of covid through the population rather than to stop it spreading altogether. This amounted in practice to accepting that herd immunity by infection was the inevitable outcome, The UK, along with many other countries in Europe and North America made a serious early error in adopting this fatalistic approach and not considering a more emphatic and rigorous approach to stopping the spread of the virus as adopted by many East and South East Asian countries. The fact that the UK approach reflected a consensus between official scientific advisers and the Government indicates a degree of groupthink that was present at the time which meant we were not as open to approaches being taken elsewhere as we should have been.

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.